載入...
Treatment response of bevacizumab combination chemotherapy in recurrent glioblastoma: A long-term retrospective study in Taiwan
Treatment options for recurrent glioblastoma are rare, with their response uncertain. This study aimed to determine the response of chemotherapy including bevacizumab in combination with vincristine and carboplatin for glioblastoma at first recurrence in a single-institution cohort. Clinical data of...
Na minha lista:
| 發表在: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wolters Kluwer Health
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7034747/ https://ncbi.nlm.nih.gov/pubmed/32080119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000019226 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|